Live Breaking News & Updates on Genezen

Stay updated with breaking news from Genezen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities

/PRNewswire/ Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5. ....

United States , Noord Holland , Connor Halverson , Steven Favaloro , Prnewswire Genezen , David Anderson , Contract Development , Manufacturing Organization , Ampersand Capital Partners , Ampersand Capital , With Ampersand , General Partner ,

Genezen Announces Presentation at 2023 Annual Meeting of the American Society of Gene and Cell Therapy

/PRNewswire/ Genezen, a leading gene and cell therapy contract development and manufacturing organization (CDMO) today announced a poster presentation at. ....

United States , Connor Halverson , Los Angeles , Steve Favaloro , Prnewswire Genezen , American Society For Gene , Technology Evaluation , Annual American Society , Cell Therapy , Quicker Method , Lentiviral Vector Physical Titer , Health Care Amp Hospitals , Medical Pharmaceuticals , Trade Show News ,

Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth

/PRNewswire/ Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral and retroviral vector. ....

United States , Noord Holland , Prnewswire Genezen , Brammer Bio , Stevenj Favaloro , Arranta Bio , Connor Halverson , Chief Executive Officer , Arbor Biotechnologies , Ampersand Capital Partners , Executive Chairman ,